AzTrials
AzTrials

Labor Induction at TermSIEGECNCT07071662

Induction of Labor in Breech Presentation

An observational study of Labor Induction at Term and Failure, run by Centre Hospitalier Universitaire, Amiens at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Breech presenting fœtus were generally not offered a trial labor induction and were instead directed toward a cesarean section. This approach often led to obstetric complications for both the mother and the fetus. Read more about this study

Who is it for?
Ages 18 years and older, women only
What is being tested?
delivery mode
How many people
102 participants
Where
1 siteFrance
Study dates
30 Jun 2025to 1 Oct 2025
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Study population: patients with a fetus in breech presentation

Who may be able to join

  • 34SA
  • singleton
  • consent for vaginal delivery
  • breech presenting

Who cannot join

  • -34SA
  • minor
  • twin pregnancy
  • refusal of vaginal delivery

Trial locations and contacts

1 site in 1 country.

France1 site
  • CHRU Amiens

    Amiens, 80480

Other trials in France

About this study

Breech presenting fœtus were generally not offered a trial labor induction and were instead directed toward a cesarean section. This approach often led to obstetric complications for both the mother and the fetus.

This study aims to offer more labor inductions to patients with a fetus in breech presentation in order to avoid the mobidity and mortality associated with systematic cesarean sections.

Being tested
delivery mode
Keywords
labor induction, failure, breech presentation
Medical subject headings
Breech Presentation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • delivery modeOther

    To observe the different modes of delivery and evaluate the characteristics of the patients as well as maternal and fetal well being in the post partum period.

Study groups in NCT07071662
Study groupRoleWhat they receive
vaginal deliveryNot described
Receives: Other: delivery mode
caesareanNot described
Receives: Other: delivery mode

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. number of vaginal delivery

    Measured: day 1

  2. Number of cesarean

    Measured: day 1

Secondary outcomes (4)
  1. number of Endometrite

    Measured: day 1

  2. lactates value

    Measured: day 1

  3. Apgar value

    Measured: day 1

  4. Number of neonatology admission

    Measured: day 1

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Jul 2025
  2. Study start30 Jun 2025
  3. Primary completion1 Oct 2025
  4. Study completion1 Oct 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Retrospective
Enrolment
102 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07071662
Sponsor's protocol ID
PI2025_843_0127
Acronym
SIEGEC
Status last verified
Mar 2026
First submitted
8 Jul 2025
Last updated
27 Mar 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Labor Induction at Term and Failure, run by Centre Hospitalier Universitaire, Amiens at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 27 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

number of vaginal delivery (time frame: day 1). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Mar 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in